Market Overview

Oppenheimer & Co. Inc Reiterates Outperform Rating on HCA Holdings Inc.


Oppenheimer & Co. Inc released a research report on HCA Holdings Inc. (NYSE: HCA) providing more clarity around operational trends and reiterating its Outperform rating.

In the report, Oppenheimer & Co. writes, “HCA reported strong y-y revenue and volume growth for the two months ended Aug 31. The decline in Medicare revenues in 2Q was driven by a shift in the case mix, primarily from declines in cardiovascular surgeries ($28M, $25M of which is expected to recur in future quarters). Overall, HCA provided additional clarity that should help the market further understand the issues faced during 2Q.”

Oppenheimer & Co. Inc has an Outperform rating and a $37.00 price target on HCA Holdings Inc., which closed yesterday at $18.40.


Related Articles (HCA)

View Comments and Join the Discussion!

Posted-In: Oppenheimer & Co.Analyst Color Analyst Ratings

Latest Ratings

YEXTDA DavidsonMaintains20.5
BYDB of A SecuritiesMaintains47.0
SAICMorgan StanleyMaintains98.0
PVHMorgan StanleyMaintains104.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at